Jump to content

Independent research summaries on kisspeptin, the KISS1 neuropeptide, and the reproductive hormone axis.

Abstract illustration of a branching neuroendocrine signal cascade from a single node to a cluster of receptors

Kisspeptin studies: KP-10 is short; KP-54 is long

What do Kisspeptin studies tell you?

kisspeptin-10 KP-10 · short form
Ten amino acids in the kisspeptin family.
Prescription context: Promise Peptides lists kisspeptin at mypromise.com in its prescription-only catalog; a licensed U.S. clinician assesses each person before prescribing and can decline.
Only U.S. patients enter this care; state rules and the proposed treatment shape the choices.
FDA's Category 2 safety listing keeps kisspeptin-10 outside routine 503A compounding. Compounded kisspeptin has no FDA approval.

A cancer team found kisspeptin while trying to slow cancer spread. Later teams studied hormones, fertility, and sexual response.

What does Kisspeptin ask the body to do?

While studying cancer spread, one team found the body instructions for kisspeptin. Hormone work later showed what this small protein messenger does.

The first protein has 145 amino acids, the building blocks of protein. Your body cuts it into four shorter forms called KP-54, KP-14, KP-13, and KP-10. The number tells you how many protein pieces are in each form. All four have the same end, which fits certain brain cells like a key in a lock [1].

That fit makes the cells more active. For cells kept alive in a dish, researchers saw the electrical charge rise about 6 millivolts for about 21 minutes. Millivolts measure a tiny electrical change, so the finding showed cell activity rather than a health benefit [4].

The active cells tell the pituitary, a small hormone gland below the brain, to put two hormones in the bloodstream. Those hormones guide the ovaries and testicles, helping your body make testosterone or estrogen.

What does that mean for you? Kisspeptin starts your own hormone chain instead of supplying a sex hormone. Kisspeptin has no FDA approval for medical use [22].

What did Kisspeptin studies try to learn?

Most studies in people were small or brief, so they don't settle how kisspeptin might fit your care. They asked five main questions.

Puberty. In 2003, a study found an inherited change in people whose puberty never began [1]. Another change was linked to early puberty in 2008 [2]. A 2012 study tied a kisspeptin change to failure of puberty to start [3]. These findings show that kisspeptin helps puberty start at the usual time.

Missing periods. These women no longer had periods because hormone messages from the brain had slowed. In 2014, KP-54, the long form, made those messages about 3-fold more frequent and about 6-fold stronger on blood tests [7]. The fertility studies explain the finding.

IVF. IVF combines an egg and sperm in a lab. These women faced dangerous swelling of the ovaries. After KP-54, eggs matured in 95% of them, and 62% had a live birth. The 2015 study found no such swelling at the amounts tested [9].

Men's hormones. In 2011, KP-10, the short form, raised the hormone directing the testicles to make testosterone [5]. Men with type 2 diabetes took part in 2013, and their readings returned to the usual range during the 11-hour test [6].

Sexual response. A 2023 study of KP-54 found brain changes tied to sexual response. Men with low desire also had 56% more penile swelling than after placebo, which looked like kisspeptin but contained none [13]. In 2022, women felt less distress and less dislike of sexual activity [14].

These studies show what changed during testing, but they don't prove that kisspeptin would treat you.

Which Kisspeptin benefits did studies show?

First, the limits: these studies were often small or short, and they don't show that kisspeptin helps outside close research care.

Men's hormones. KP-10 is the short form. In healthy men, it raised the brain hormone that starts testosterone production. That hormone and testosterone rose within minutes [5]. Kisspeptin asked each man's body to make testosterone; it didn't supply testosterone.

Periods and fertility. KP-54 briefly brought back hormone pulses after the women's periods had ended [7]. Those pulses come before egg release, but the response grew weaker when kisspeptin was given without a break.

IVF safety. These women had a high risk of swollen ovaries. KP-54 helped eggs mature without pushing the ovaries in the usual way. The Phase 2 trial was an early study in people, and no case was rated critical, severe, or moderate [9].

Sexual response. The test included people with low desire. They received kisspeptin or a placebo, which looked like the real treatment but held no kisspeptin. They reported changes in desire and distress [13][14].

Short-term safety. A 2025 review covered more than 1,000 separate doses, not that many different people. Some people received more than one, and the review found no serious harm [22]. A second 2025 study included 95 people. KP-54 raised the egg-release hormone. Anxiety, blood pressure, and cortisol, a hormone that rises with stress, did not rise over placebo [21].

For you, these are limited findings, not promises. The Kisspeptin dosage page describes the amounts studied.

How did Kisspeptin move the hormone chain?

Kisspeptin made certain brain cells send the first hormone message. The message went to the pituitary, the small hormone gland below the brain. From there, two hormones entered the bloodstream. One helps men make testosterone and release an egg, while the second helps eggs and sperm develop.

In studies of people, KP-10, the short form, went into a vein through a steady drip. The amount depended on body weight and time. The first hormone stayed higher, and testosterone rose too. Participants included healthy men, plus men with type 2 diabetes whose testosterone was a little low [5][6].

Kisspeptin isn't testosterone, estrogen, or any other sex hormone; it asks your own hormone chain to work. If a later part of that chain fails, your full response may fail too.

For you, a changed blood test isn't the same as a proven health gain.

Did Kisspeptin raise testosterone in men?

The studies in men were small and closely watched. Within those limits, KP-10 raised testosterone by starting each man's own hormone chain.

Healthy men received KP-10 through a vein. The hormone directing the testicles rose along with testosterone, though the 2011 study didn't test long-term care [5].

A 2013 study included men with type 2 diabetes and mildly low testosterone. The first hormone rose about 2-fold. Testosterone reached the usual range during the 11-hour study, and the response didn't fade [6].

Kisspeptin acts earlier in the chain; it isn't testosterone. Any effect for you would depend on your pituitary gland and testicles working. The questions page explains that limit.